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Adhesion is the initial event in the establishment of any infection. Borrelia burgdorferi,
the etiological agent of Lyme disease, possesses myriad proteins termed adhesins that
facilitate contact with its vertebrate hosts. B. burgdorferi adheres to host tissues through
interactions with host cells and extracellular matrix, as well as other molecules present in
serum and extracellular fluids. These interactions, both general and specific, are critical in
the establishment of infection. Modulation of borrelial adhesion to host tissues affects the
microorganisms’s ability to colonize, disseminate, and persist. In this review, we update
the current knowledge on structure, function, and role in pathogenesis of these “sticky”
B. burgdorferi infection-associated proteins.
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INTRODUCTION
Spirochetes are unique among bacteria in their extraordinary
ability to invade, disseminate, and persist in their hosts. There
is no invasion, dissemination, or persistence, however, without
the ability to first adhere to host cells and surfaces. Adhesion is
the initial event in the establishment of any infection. Failure to
bind with sufficient strength to host tissues results in the bac-
terial pathogen’s clearance by host innate immune mechanisms.
Binding too strongly to host tissues can be detrimental to the
pathogen, however, by hindering the ability of the bacterium
to disseminate throughout the host. To facilitate this dynamic
attachment, bacteria possess proteins called adhesins that enable
binding to specific host molecules. A major adhesive target of
bacterial pathogens is the extracellular matrix (ECM), a com-
plex network of proteins and carbohydrates between and beneath
cells. This supportive lattice typically functions in eukaryotic
cell movement, development, and growth (Lodish and Darnell,
2000).
Lyme disease is the most common arthropod-borne disease in
the northern hemisphere, and is caused by species of the Borrelia
burgdorferi sensu lato complex, which includes B. burgdorferi
sensu stricto (henceforth B. burgdorferi), B. garinii, B. afzelii,
B. spielmanii, and B. bavariensis (Margos et al., 2011; Stanek and
Reiter, 2011; Stanek et al., 2012). The Lyme disease spirochete
can infect immunocompetent humans and other vertebrates for
extensive periods of time, even for the animal’s lifetime (Moody
et al., 1990; de Souza et al., 1993; Steere, 2001; Miller et al., 2003;
Stanek et al., 2012). As an extracellular pathogen, B. burgdor-
feri interacts with cells, tissues, and components of the ECM.
In vivo, B. burgdorferi is frequently found associated with con-
nective tissues (Kornblatt et al., 1984; De Koning et al., 1987;
Barthold et al., 1991, 1992a,b, 1993; Defosse et al., 1992; Häupl
et al., 1993; Pachner et al., 1995; Franz et al., 2001; Coburn et al.,
2002; Cadavid et al., 2003; Cabello et al., 2007) and detected in
infected cartilaginous tissues, such as skin and joints (Kornblatt
et al., 1984; Schwan et al., 1988; Sinsky and Piesman, 1989;
Barthold et al., 1991, 1992b; Melchers et al., 1991; Berger et al.,
1992; Defosse et al., 1992; Schwartz et al., 1992; Shih et al., 1992;
Pachner et al., 1995; Coburn et al., 2002; Liveris et al., 2002;
Miller et al., 2006; Bykowski et al., 2007). Indeed, the ability of
B. burgdorferi to invade collagenous tissue has been suggested
as a possible mechanism of immune evasion (Cadavid et al.,
2003; Barthold et al., 2006; Cabello et al., 2007). B. burgdorferi
interactions with the host ECM are therefore likely critical in
both the spirochete’s pathogenesis as well as its persistence in
mammals.
B. burgdorferi binds various components of the ECM, includ-
ing glycosaminoglycans (GAGS), fibronectin, decorin, collagen,
laminin, and integrins. In addition, B. burgdorferi adheres to
numerous host cell types and binds components of host serum
and extracellular fluids, such as plasminogen and complement
regulators (Table 1). A number of B. burgdorferi adhesins were
recently reviewed by Antonara et al. (2011). However, consid-
erable research into the functions and biomolecular interac-
tions of these adhesins has taken place since then, including
the identification of novel Lyme spirochete adhesins. In this
review, we provide an update on B. burgdorferi adhesins,
focusing specifically on the bacterial factors that interact
with components of the ECM, plasminogen, and complement
regulators. For readers interested in adhesins involved in spiro-
chete/tick interactions, please refer to the recent review by
Kung et al. (2013). We would also refer the reader to the
excellent discussion of novel in vivo imaging techniques and
their use in delineating the roles of B. burgdorferi adhesins
in a infectious mouse model in the work of Coburn et al.
(2013).
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Table 1 | B. burgdorferi adhesins.
Function Adhesin (genetic
locus)
Comments References
FIBRONECTIN BINDING
BBK32 (bbk32) Also binds GAGs; mutants attenuated in mice; role in
vascular interactions in mice
Probert and Johnson, 1998; Probert et al., 2001; Kim et al., 2004; Raibaud
et al., 2005; Fischer et al., 2006; Li et al., 2006; Seshu et al., 2006;
Norman et al., 2008; Hyde et al., 2011; Chan et al., 2012; Lin et al., 2012;
Moriarty et al., 2012
RevA (bbM27,
bbP27 )
bbM27 attenuated in mice; early antigen of Lyme
disease; not involved in vascular interactions in mice
Gilmore and Mbow, 1998; Carroll et al., 2001; Mbow et al., 2002;
Brissette et al., 2009a, 2010; Lin et al., 2012; Moriarty et al., 2012; Floden
et al., 2013
RevB (bbC10) Attenuated in mice; not involved in vascular
interactions in mice
Brissette et al., 2009a, 2010; Lin et al., 2012; Moriarty et al., 2012
BB0347 (bb0347 ) Not involved in vascular interactions in mice Moriarty et al., 2012; Gaultney et al., 2013
CspA (bbA68) Also binds complement regulator proteins,
plasminogen, laminin, others
Hallstrom et al., 2010
CspZ (bbH06) Also binds complement regulator proteins, laminin Hallstrom et al., 2010
GAG BINDING
DbpA/B (bbA24,
bbA25)
Bind decorin and dermatan sulfate; attenuation of
infection in mice
Fischer et al., 2003; Shi et al., 2006; Blevins et al., 2008; Shi et al.,
2008a,b; Benoit et al., 2011; Hyde et al., 2011; Chan et al., 2012; Lin et al.,
2012; Wang, 2012; Imai et al., 2013; Morgan and Wang, 2013
Bgp (bb0588) Attenuated in mice Parveen et al., 2006; Lin et al., 2012
BbhtrA (bb104) Binds and cleaves aggregan; first cell-associated
protease described in B. burgdorferi
Coleman et al., 2013; Kariu et al., 2013; Russell and Johnson, 2013;
Russell et al., 2013
LAMININ BINDING
BmpA (bb0382) Potential role in arthritis Pal et al., 2008; Yang et al., 2008; Verma et al., 2009
ErpX (on lp56 of
B31)
Brissette et al., 2009c
CspA (bbA68) Also binds complement regulator proteins,
plasminogen, fibronectin, others
Hallstrom et al., 2010
CspZ (bbH06) Also binds complement regulator proteins,
plasminogen, fibronectin, others
Hallstrom et al., 2010
COLLAGEN BINDING
Zambrano et al., 2004
CspA (bbA68) Also binds complement regulator proteins,
plasminogen, fibronectin, others
Hallstrom et al., 2010
CspZ (bbH06) Also binds complement regulator proteins, laminin,
fibronectin
Hallstrom et al., 2010
INTEGRIN BINDING
P66 (bb0603) Binds α1β3; also porin; essential for infection of mice Antonara et al., 2007; Behera et al., 2008; Lafrance et al., 2011; Ristow
et al., 2012
BB0172 (bb0172) Binds α3β1; MIDAS motif Wood et al., 2013
PLASMINOGEN BINDING
BB0337(bb0337 ) Enolase; moonlighting protein Floden et al., 2011; Nogueira et al., 2012; Toledo et al., 2012
OspC (bbB19) Required for establishment of infection Grimm et al., 2004; Tilly et al., 2006; Antonara et al., 2007, 2010; Tilly
et al., 2007; Xu et al., 2008; Lin et al., 2012; Onder et al., 2012
CspA (bbA68) Also binds complement regulator proteins, laminin,
others
Hallstrom et al., 2010; Hammerschmidt et al., 2014
BBA70 (bbA70) Koenigs et al., 2013
ErpA/C/P (bbP38,
bbI39, bbN38)
ErpA mutants have slight attenuation in mice Alitalo et al., 2002; Brissette et al., 2009b; Lin et al., 2012
COMPLEMENT REGULATOR BINDING
Kraiczy and Stevenson, 2013
CspA (bbA68) Binds FH, FHL-1 Hellwage et al., 2001; Alitalo et al., 2002; Metts et al., 2003; Hallstrom
et al., 2010; Caesar et al., 2013b; Hammerschmidt et al., 2014
CspZ (bbH06) Binds FH, FHL-1 Hartmann et al., 2006; Rogers and Marconi, 2007; Kraiczy et al., 2008;
Rogers et al., 2009
ErpA/C/P (bbP38,
bbI39, bbN38)
Bind FH, different binding affinities for FHR1, 2, 5 Kenedy et al., 2009; Hammerschmidt et al., 2012; Bhattacharjee et al.,
2013; Caesar et al., 2013a; Meri et al., 2013
Abbreviations: Bgp, Borrelia glycosaminoglycan-binding protein; Bmp, Borrelia membrane protein; Dbp, decorin binding protein; Erp, OspEF-related protein; FHL,
factor H-like; FHR-1, factor H related-1; GAG, glycosaminoglycan.
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FIBRONECTIN BINDING PROTEINS
Fibronectin is a large plasma glycoprotein and a prominent com-
ponent of the ECM and host serum (Romberger, 1997). In the
uninfected host, fibronectin has many important roles including
involvement in cell adhesion, cell migration, cell-cell signaling,
ECM remodeling, and cell proliferation, survival and differ-
entiation (Hynes, 1999; Pankov and Yamada, 2002; Midwood
et al., 2006). Many bacterial pathogens interact with fibronectin,
including several pathogenic spirochetes (Fitzgerald et al., 1984;
Umemoto et al., 1993; Kopp et al., 1995; Grab et al., 1998;
Probert and Johnson, 1998; Merien et al., 2000; Probert et al.,
2001; Cameron et al., 2004; Schwarz-Linek et al., 2004, 2006;
Choy et al., 2007; Lee and Choi, 2007; Stevenson et al., 2007;
Atzingen et al., 2008; Brinkman et al., 2008; Hauk et al., 2008;
Brissette et al., 2009a; Bamford et al., 2010; Henderson et al.,
2011). B. burgdorferi binds to fibronectin in vitro (Kopp et al.,
1995; Grab et al., 1998; Probert and Johnson, 1998). Additionally,
soluble fibronectin or anti-fibronectin antibodies inhibit interac-
tions between B. burgdorferi and cultured endothelial cells and
their secreted matrices (Szczepanski et al., 1990; Kopp et al.,
1995). In vivo, fibronectin interactions are critical in the initia-
tion of borrelial interactions with the microvasculature (Norman
et al., 2008). To date, there have been five fibronectin binding pro-
teins identified in B. burgdorferi: BBK32, RevA/B, BB0347, and
CspA (CRASP-1).
BBK32
BBK32, a 47 kDa protein encoded on linear plasmid 36 (lp36),
binds the glycosaminoglycans heparin sulfate and dermatan sul-
fate, in addition to fibronectin. BBK32 was the first fibronectin-
binding protein identified in B. burgdorferi (Probert and Johnson,
1998; Probert et al., 2001). BBK32 deletion mutants demonstrate
a slight, but significant, defect in infectivity in the mouse (Li et al.,
2006; Seshu et al., 2006). BBK32 has sequence similarities with
fibronectin-binding adhesins of Gram-positive pathogens such as
Staphylococcus aureus and the streptococci. Indeed, BBK32 inter-
acts with fibronectin via the “tandem beta zipper” mechanism
that is common for fibronectin-binding adhesins of streptococci
(Kim et al., 2004; Raibaud et al., 2005). Several recent studies have
investigated the functions of BBK32 in B. burgdorferi pathogene-
sis (Hyde et al., 2011; Wu et al., 2011; Chan et al., 2012; Moriarty
et al., 2012; Ranka et al., 2013).
Recently, a whole body imaging system was utilized to exam-
ine the role of BBK32 in dissemination throughout the murine
host (Hyde et al., 2011). Luciferase-expressing B. burgdorferi lack-
ing BBK32 were injected into mice. The authors demonstrated
a decrease in the infectious load of bbk32 mutants at days 4
and 7 compared to the parental strain. Dissemination defects
were more pronounced at lower inocula, and disappeared with
higher doses of bacteria and with later time points (14 days
post-inoculation). These data are consistent with the infectiv-
ity phenotypes observed in previous studies, which implied that
BBK32 is important in the earlier stages of infection (Li et al.,
2006; Seshu et al., 2006). The imaging results correlated well with
quantitative PCR data, suggesting that whole body imaging may
be a useful tool to discern subtle differences in colonization and
dissemination with other borrelial mutants. These studies are also
significant as the first use of bioluminescent imaging in mice with
B. burgdorferimutants (Hyde et al., 2011).
Elegant studies recently have demonstrated the involvement of
BBK32 in adhesion to the vasculature through the use of intravital
microscopy (Moriarty et al., 2012). BBK32-fibronectin interac-
tions were shown to be important for the initial tethering of
the bacterium to the endothelium, a process termed “molecular
braking.” This transient slow- down allowed for more stable inter-
actions between BBK32 and glycosaminoglycans, leading to drag-
ging of the bacterium along the endothelium, stationary adhesion
of the bacterium to the endothelium, transmigration, and, finally,
escape from the vasculature in a manner akin to the diapedesis of
leukocytes (Muller, 2009). BBK32-deficient bacteria had signifi-
cantly reduced interactions per minute, but still adhered to the
endothelium, signifying that other adhesins are involved in the
initial tethering step. The authors looked at the potential role of
other fibronectin-binding proteins; gain of function studies were
performed with a high passage nonadherent strain of B. burgdor-
feri overexpressing RevA, RevB, or BB0347. None of these proteins
acted as vascular adhesins in fluid shear forces under the con-
ditions of this experiment (Moriarty et al., 2012), suggesting
additional borrelial adhesins (fibronectin binding or otherwise)
are involved.
Another study evaluated a B. burgdorferi strain, N40D10/E9,
which naturally lacks bbk32 and has decreased binding to Vero
(epithelial) cells. This strain disseminated at lower doses than the
B. burgdorferi type strain, which does possess BBK32. The authors
postulate this difference may be due to the lack of binding of the
bacteria to epithelial cells at the site of inoculation (Chan et al.,
2012). An important point gleaned from the above two studies is
that while adhesion is a critical virulence factor for B. burgdorferi,
that adhesion must be modulated to allow the bacterium to dis-
seminate, either hematogenously or through the tissues. Adhering
too strongly to tissues or cells is likely just as detrimental as not
adhering at all.
B. burgdorferi is generally considered an extracellular
pathogen, although there are numerous studies demonstrating
at least transient intracellularity (Ma et al., 1991; Klempner
et al., 1993; Dorward et al., 1997; Livengood and Gilmore,
2006). Recently, specific integrins were shown to be involved in
B. burgdorferi invasion of mouse fibroblasts and human umbilical
vein endothelial cells (HUVEC) (Wu et al., 2011). Since these
integrins interact with fibronectin, Wu et al. examined the role of
BBK32 as a bridge in the uptake of B. burgdorferi. BBK32 was not
involved in the invasion of B. burgdorferi into murine fibroblasts,
human fibroblasts or HUVECs, suggesting other components
(such as additional fibronectin binding proteins) of B. burgdorferi
interact with integrins to trigger uptake (Wu et al., 2011).
However, BBK32 protein fragments were used for the success-
ful intracellular targeting of nanoparticles into epithelial cells,
based on a Hepatitis B core protein system. Hepatitis B virus
core is a 21 kDa protein which self-assembles into 35 nm particles
(Wynne et al., 1999). Using region 130–166 of BBK32 (fibronectin
binding region) fused into the major immunodominant region
of the Hepatitis B core antigen, the authors demonstrated both
fibronectin binding and uptake of the engineered nanoparticles
into baby hamster kidney cells (Ranka et al., 2013). Targeting
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nanoparticles to cells or tissues of interest using a bacterial
adhesin might be an efficient approach for drug delivery.
RevA/B
RevA is a 19 kDa surface protein encoded on the circular plas-
mid 32 (cp32) family of plasmids. RevB is encoded on cp9, and
shares 28% overall amino acid sequence identity with RevA.
RevA expression is upregulated in the mammal compared to
the tick vector, and its expression pattern and surface exposure
suggest a potential role in B. burgdorferi pathogenesis (Gilmore
and Mbow, 1998; Carroll et al., 2001; Mbow et al., 2002;
Brissette et al., 2009a). Both RevA and RevB were shown to bind
fibronectin in vitro, and anti-RevA antibodies block binding of
whole B. burgdorferi to fibronectin (Brissette et al., 2009a).
Recently, the potential for RevA to serve as a diagnostic tool or
vaccine was evaluated. RevA is expressed early upon mammalian
infection, and patients in various stages of Lyme disease, includ-
ing patients with erythema migrans, exhibited antibodies to this
protein (Brissette et al., 2010). In contrast, RevB lacked utility as
a potential diagnostic marker; patients rarely possessed antibod-
ies to RevB, probably because cp9 is a plasmid often lost even in
infectious wild-type Borrelia (Brissette et al., 2010). In mice, there
was a rapid IgM response to RevA, which remained steady over
months, and was followed by a variable IgG response. Polyclonal
rabbit anti-RevA antibodies were bactericidal in vitro, but serum
from vaccinated mice was not. Mice vaccinated with RevA were
not protected when exposed to B. burgdorferi by needle or tick
bite (Floden et al., 2013); however, passive immunization with
the bactericidal rabbit anti-RevA antibodies did prevent infection.
The reason for this disparity is not known; a bolus of anti-RevA
antibody concentrated near the site of infection may be necessary
for the observed bactericidal effect.
In addition to their bactericidal effects, antibodies against
adhesins can block critical interactions between bacteria and
their host. Schmit and colleagues investigated the ability of var-
ious monoclonal antibodies against B. burgdorferi outer surface
proteins to block binding of the spirochete to human cells.
Monoclonal antibodies against RevA did not prevent binding
of B. burgdorferi to HUVECS or H4 neuroglial cells (Schmit
et al., 2011). Since monoclonal antibodies were used, it is pos-
sible that polyclonal antibodies recognizing multiple epitopes of
RevA could block binding of the bacterium to cells. Indeed, a
polyclonal antibody against RevA prevents binding of B. burgdor-
feri to immobilized fibronectin (Brissette et al., 2009a). However,
nonadherent B. burgdorferi overexpressing RevA did not exhibit
increased binding to the vascular endothelium in vivo, which
suggests this adhesin is not involved in endothelial cell interac-
tions (Moriarty et al., 2012). RevA’s role in pathogenesis remains
to be elucidated; however, a revA mutant uncovered in a global
signature-tagged mutagenesis study did demonstrate an infectiv-
ity defect (Lin et al., 2012). It is likely that many borrelial adhesins
have distinct tissue and cell type tropisms, as well as overlapping
and redundant functions.
BB0347
The chromosomally-encoded protein BB0347 was recently con-
firmed to bind fibronectin by two independent studies (Moriarty
et al., 2012; Gaultney et al., 2013). Previously, BB0347 had
been annotated as a putative fibronectin binding protein due to
sequence similarity with other such proteins (Fraser et al., 1997).
Gaultney et al. demonstrated that BB0347 was expressed and
surface exposed, and that mice infected with live B. burgdorferi
produced anti-BB0347 antibodies (Gaultney et al., 2013). The
importance of BB0347 in murine infection has not been thor-
oughly tested; however, overexpression of this protein does not
restore the ability of noninfectious, nonadherent B. burgdorferi to
bind host vasculature (Moriarty et al., 2012). Additionally, results
suggest that BB0347 has a higher dissociation constant (KD)
than BBK32, suggesting this protein does not bind fibronectin as
strongly (Moriarty et al., 2012; Gaultney et al., 2013). Ultimately,
the role of BB0347 in B. burgdorferi pathogenesis is still largely
unknown, and further research is needed to determine the func-
tionality of this protein in the Lyme spirochete.
CspA (CRASP-1)
CspA, also known as Complement Regulator Acquiring Surface
Protein-1 (CRASP-1), is a factor H binding protein important in
Borrelia resistance to complement (Kraiczy et al., 2001b; Brooks
et al., 2005). Likemany B. burgdorferi adhesins, CspA hasmultiple
functions and binding partners (Kraiczy et al., 2001a; Hallstrom
et al., 2010). Recent work by Hallstrom et al. demonstrated that
CspA binds to fibronectin in vitro, as well as to human bone mor-
phogenic protein 2 (BMP2), plasminogen, collagens I, III, and
IV, and laminin. CspZ (CRASP-2), another factor H binding pro-
tein, also bound fibronectin and laminin in vitro (Hallstrom et al.,
2010).
PROTEOGLYCAN AND GAG BINDING PROTEINS
Proteoglycans are a diverse group of highly viscous macro-
molecules with a core protein and attached polysaccharide chains
called glycosaminoglycans, or GAGs (Lodish and Darnell, 2000).
Glycosaminoglycans, including chondroitin sulfate, dermatan
sulfate, keratin sulfate, heparin, heparin sulfate, and hyaluronan,
are long unbranched polysaccharides comprised of a repeating
disaccharide unit (Varki, 2009). B. burgdorferi binds to both pro-
teoglycans and their GAG chains through a number of proteins,
including decorin-binding proteins A and B (DbpA/B), Borrelia
glycosaminoglycan- binding protein (Bgp), and BBK32 (Parveen
and Leong, 2000; Fischer et al., 2003, 2006).
Decorin-binding protein A/B
Decorin is a small leucine rich proteoglycan that associates with
collagen; it possesses a collagen binding core protein and sin-
gle GAG chain, either dermatan sulfate or chondroitin-6 sulfate
(Danielson et al., 1997; Keene et al., 2000; Zhang et al., 2006).
Decorin is widely expressed, and has important functions not
only as a structural molecule of the ECM, but also as a cell signal-
ing molecule influencing growth, differentiation, and inflamma-
tion (Dugan et al., 2006). Decorin also interacts with fibrinogen,
allowing interaction with the hemostasis and thrombosis cas-
cades (Dugan et al., 2006; Seidler, 2012). B. burgdorferi has two
decorin-binding proteins that recognize decorin and other pro-
teoglycans with GAG chains (Guo et al., 1995, 1998; Leong et al.,
1998; Parveen et al., 1999). The genes encoding decorin-binding
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proteins A and B (dbpA/B) are encoded in a bicistronic operon
on lp54. Mutants deficient in decorin- binding proteins are still
infectious; however, dbpA/B deficient bacteria are impaired in
both colonization of various tissues and in persistent infection
(Shi et al., 2006, 2008a,b; Weening et al., 2008). Decorin defi-
cient mice are resistant to B. burgdorferi, exhibiting fewer bacteria
in joints upon infection as well as less severe arthritis than that
induced in wild type mice (Brown et al., 2001). These data high-
light the importance of decorin interactions to the establishment
of disseminated infections by B. burgdorferi.
The recently solved structure of DbpA lends insight into the
biophysical interaction of this protein with GAGs (Wang, 2012).
DbpA was shown to be a helical bundle protein with 5 helices
and a strong hydrophobic core. The authors demonstrated that a
patch composed of basic amino acids is formed by portions of two
helices and two flexible linkers. Residues K163, K170, and R166
formed a basic stretch on helix 5, reminiscent of motifs present
in other GAG-binding helices. Heparin titration of DbpA showed
that perturbed residues were in the linker domain between helices
1 and 2, demonstrating an important role for this linker in bind-
ing GAGs. Dermatan sulfate binds with a lower affinity than
heparin, but still binds DbpA (Wang, 2012). In a separate study,
the heparin binding epitope was identified as a BXBB motif
(B= basic amino acid) in the linker between helices 1 and 2
(Morgan and Wang, 2013).
Based on the structural data, it seems likely that DbpA allelic
variation, particularly in the GAG binding region, would affect
the ability of B. burgdorferi to bind to decorin, GAGs, and mam-
malian cells. In gain of function studies, B314, a noninfectious
and nonadherent B. burgdorferi strain, was used to examine the
binding characteristics of various DpbA alleles. Expression of var-
ious alleles of DbpA in the nonadherent background allowed
adhesion to epithelial but not endothelial or glial cells (Benoit
et al., 2011). The authors also demonstrated that decorin and
dermatan sulfate binding were separable, suggesting different
binding sites on the DbpA protein for decorin and dermatan
sulfate. The DbpA protein from strain N40 showed reduced
adhesion to GAGs in vitro; however, the N40 strain caused dis-
seminated infection in vivo (Chan et al., 2012), suggesting that
other adhesins are crucial for adhesion and dissemination in this
strain. An alternative explanation is that the recombinant protein
used for in vitro studies may have different binding activities than
the native borrelial protein.
Another group examined decorin binding of various
genospecies including B. afzelii, B. garinii, and B. burgdorferi
sensu stricto (Salo et al., 2011). There is only 40–60% similarity
among the decorin binding proteins of these genospecies.
Interestingly, B. afzelii, despite its preference for skin and its
association with the Lyme disease skin manifestation known as
acrodermatitis chronica atrophicans, doesn’t bind decorin. The
authors evaluated the binding abilities of both DbpA and DbpB
independently. DbpA of B. garinii, as well as DbpB of B. garinii
and B. burgdorferi, promoted strong binding to decorin. In
contrast, DbpA of B. burgdorferi and DbpA and DbpB of B. afzelii
exhibited lower binding to decorin. Despite differences in their
binding to decorin in vitro, both DbpA and DbpB of B. garinii, as
well as B. burgdorferi, promoted adhesion of whole spirochetes
to decorin or decorin-expressing human foreskin fibroblasts
(Salo et al., 2011). The authors suggest that the Dbps of B. afzelii
have different biological functions and ligands than the Dbps of
B. garinii or B. burgdorferi.
In a previously mentioned study with BBK32, luciferase-
expressing B. burgdorferi lacking dbpAB were also injected into
mice, and mutants were only visible at 1 h post infection (Hyde
et al., 2011), suggesting efficient clearance of the spirochetes.
These data again demonstrate a role for decorin-binding proteins
in the initial colonization by B. burgdorferi.
Another group demonstrated that DbpA/B mutants have
decreased infectivity and an early dissemination defect in
immunocompetent but not immunodeficient mice. Development
of arthritis and carditis decreased only in early stages of infection
with DbpA/B mutants in either strain of mice. Up to 14 days post
infection, the bacterial load in the lymph nodes of mice infected
withDbpA/Bmutants was decreased compared to lymph nodes of
mice infected with wild type bacteria. The authors postulate that
the immune response restricts early dissemination through the
lymphatic system, which suggests a role for nonantibody medi-
ated clearance, perhaps by iNKT cells. A particular adhesin may
not be essential for infection, but can still influence pathogenicity
by altering the course of infection through changing the ability to
disseminate, colonize, or persist (Imai et al., 2013).
Finally, anti-DbpA antibodies were shown to significantly
reduce the ability of whole B. burgdorferi to bind to H4 (neu-
roglial) and HUVEC cells. Indeed, dbpA expression was increased
when B. burgdorferi was incubated with either cell type (Schmit
et al., 2011). Overall, the data amassed in the last 3 years demon-
strate that decorin binding proteins of B. burgdorferi are impor-
tant in both the initial establishment of infection and persistence
of the Lyme spirochete.
BbhtrA
The proteoglycan aggrecan is found in the ECM and cartilage,
particularly articular cartilage of joints. Aggrecan is comprised of
three globular domains, with 2 sites for GAG attachment. The
N terminus of aggrecan binds hyaluronan, which is important
for linking of aggrecan molecules to form aggregates (Watanabe
et al., 1998). Aggrecan thus adds to the resiliency of functional
cartilage. B. burgdorferi binds aggrecan, and both BbhtrA and
Bgp were recently identified as aggrecan-binding proteins (Russell
and Johnson, 2013). BbhtrA is significant as the first identified
outer surface protease of B. burgdorferi. BbhtrA is expressed dur-
ing human disease, is immunogenic, and is conserved among
B. burgdorferi strains. BbhtrA both binds and cleaves aggrecan at a
site known to eradicate its function, suggesting that this protease
may contribute to the damage seen in Lyme arthritis (Russell and
Johnson, 2013). Proteolytic activity for BbhtrA against B. burgdor-
feri proteins BB0323, BmpD, and CheX was also demonstrated, in
addition to cleavage of host ECM proteins (Coleman et al., 2013;
Kariu et al., 2013; Russell et al., 2013).
COLLAGEN-BINDING PROTEINS
Collagens are triple helical proteins and the most abundant
ECM proteins. Collagens are important structural compo-
nents of many tissues, allowing tissues to withstand stretching
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(Lodish and Darnell, 2000). There are numerous collagens and
related proteins. Collagens I, II, and III are the major fibrous
collagens, while collagen IV is a major constituent of basement
membranes (Labat-Robert et al., 1990). B. burgdorferi has long
been known to bind collagen in vitro, but until recently no col-
lagen binding adhesin had been identified (Zambrano et al.,
2004). Hallstrom and colleagues recently demonstrated that CspA
(CRASP-1), a factor H binding protein, also binds to collagen I,
III, and IV (Hallstrom et al., 2010). More studies are necessary to
elucidate the multiple roles of CspA in B. burgdorferi pathogene-
sis. Given the spirochete’s redundant interactions with other ECM
proteins, it is likely that other collagen binding adhesins remain to
be discovered.
LAMININ-BINDING PROTEINS
Laminin is a glycoprotein component of the ECM consisting of α,
β, and γ subunits that self-assemble into a heterotrimer. Laminin
serves a scaffolding function and interacts with integrins as well
as other matrix components (Colognato and Yurchenco, 2000).
B. burgdorferi binds laminin through BmpA and ErpX (Brissette
et al., 2009c; Verma et al., 2009). Recently, the promiscuous CspA
and CspZ proteins were also shown to bind laminin in vitro
(Hallstrom et al., 2010).
INTEGRIN-BINDING PROTEINS
Integrins are transmembrane bidirectional signaling molecules
involved in cell-cell signaling and cell-matrix interactions.
Intergins serve as ECM ligands and partner withmanymultiadhe-
sive proteins including fibronectin, laminin, and collagen (Takada
et al., 2007). These heterodimeric proteins consist of both α and β
subunits. B. burgdorferi binds αIIβ3 (Coburn et al., 1993), αvβ3,
α5β1 (Coburn et al., 1998), as well as α3β1 integrins (Behera et al.,
2006).
B. burgdorferi binds α1β3 integrins through the P66 outer
membrane protein and porin (Lafrance et al., 2011). Because of
the ability of integrins to signal “outside-in,” the authors exam-
ined the effects of P66 on gene expression by human cells in
culture. B. burgdorferi strains with and without P66 were incu-
bated with EA-hy926 (endothelial) cells or human embryonic
kidney cells (HEK 293) and subjected to microarray analysis. For
both cells, but especially the endothelial cells, there were dra-
matic changes in the expression of ECM interacting proteins,
components of the immune response, and genes encoding pro-
teins involved in actin dynamics. The authors postulate that P66
may decrease the endothelial cell response, which in turn affects
the ability of the endothelium to respond to the bacterial threat
(Lafrance et al., 2011).
P66 strains were not infectious in wild type, TLR2-, or
MyD88- mice, suggesting that even in the absence of innate
immune signaling, P66 is required to establish infection (Ristow
et al., 2012). Interestingly, restoration of P66 on a shuttle vec-
tor did not restore infectious ability, but complementation on
the chromosome did, supporting the hypothesis that transient
adhesion is important (i.e., the overexpressing complemented
strain was not infectious). P66 mutants were cleared from site
of inoculation, but survived in rat dialysis chambers. These data
demonstrated that the inability to infect mice was not due to
a nutritional defect, an important point as P66 is a porin as
well as an adhesin. P66 was not required for survival in ticks,
as P66 mutants survived in the tick through the molt from
larvae to nymph. Increased mast cells were present at the site
of inoculation of P66 strains, and the mutants did not show
increased susceptibility to serum. The authors suggest that P66
binding to integrins is necessary to move from the site of inocula-
tion to distant tissues (Ristow et al., 2012). The exact connection
between the lack of P66 and bacterial clearance remains to be
established.
Integrins were also shown to be involved in invasion of human
endothelial cells and mouse fibroblasts by B. burgdorferi. This
process required β1 integrins but not α5β1 or the fibronectin
binding protein BBK32. Internalization did require actin reorga-
nization, as well as Src kinase activity (Wu et al., 2011).
Wood et al. recently described a novel integrin binding fac-
tor (Wood et al., 2013). The protein encoded by bb0172 was
shown to be associated with the outer membrane by proteinase
K digestion and Triton X-114 extraction. This protein bound
α3β1 integrin, and has a von Willebrand factor (vWF) domain,
which is oriented to the extracellular environment. vWF domains
are important in both cell adhesion and protein-protein interac-
tions (Schneppenheim and Budde, 2011). Changes in tempera-
ture affected bb0172 expression, which was increased during the
change from unfed to fed tick conditions in vitro. BB0172 was
shown to be a metal ion-dependent integrin binding protein, and
this paper marks the first report of a metal ion-dependent adhe-
sion site (MIDAS) motif in Borrelia species. Of particular note
from this study is the use of an in vitro system to determine the
orientation of transmembrane helices inmicrosomalmembranes;
this may be a helpful tool for studying other helical membrane
proteins of B. burgdorferi and other spirochetes (Wood et al.,
2013).
PLASMINOGEN-BINDING PROTEINS
Plasmin is a serine protease synthesized as the inactive zymogen
plasminogen. Plasminogen is activated by physiological activators
uPA (urokinase plasminogen activator) or tPA (tissue plasmino-
gen activator) to the active serine protease plasmin. Plasmin’s
main role in vivo is to degrade fibrin-containing thrombi, but
it can also degrade ECM components (Castellino and Ploplis,
2005). Plasminogen is abundant in serum and extracellular flu-
ids, and is a favorite target of many pathogenic bacteria. Binding
plasminogen to the surface of a bacterium can provide a potent
protease that can assist in dissemination and invasion of the
pathogen (Bhattacharya et al., 2012; Sanderson-Smith et al.,
2012). Several plasminogen-binding proteins have been identi-
fied in B. burgdorferi, including OspA, OspC, ErpA/C/P, CspA,
CspZ, BBA70, enolase, and a 70 kDa protein (Fuchs et al., 1994;
Hu et al., 1997; Lagal et al., 2006; Brissette et al., 2009b; Hallstrom
et al., 2010; Koenigs et al., 2013; Hammerschmidt et al., 2014).
Plasminogen deficient mice have decreased spirochetemia upon
B. burgdorferi infection (Coleman et al., 1997). Plasmin on the
surface of B. burgdorferi facilitates movement through endothelial
cell monolayers and degrades components of the ECM (Coleman
et al., 1995, 1999). Clearly, acquisition of plasminogen is vital for
efficient dissemination of B. burgdorferi.
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Enolase
Enolase is a highly conserved glycolytic enzyme that should
be cytosolic, as it lacks classical cell sorting sequences and cell
anchoring moieties. Yet, enolase is a prime example of a “moon-
lighting” protein (Jeffery, 1999) that is found on the surface of a
variety of eukaryotic cells where it can function as a plasminogen
receptor (Pancholi, 2001). A number of bacteria express enolases,
which likewise can be found on the surface of bacterial cells and
function as plasminogen receptors (Pancholi and Fischetti, 1998;
Lahteenmaki et al., 2001; Pancholi and Chhatwal, 2003).
Three research groups published that B. burgdorferi enolase,
BB0337, is a plasminogen-binding protein (Floden et al., 2011;
Nogueira et al., 2012; Toledo et al., 2012). Floden et al. demon-
strated that this binding was dependent on lysine residues but
not influenced by ionic charge. Enolase was localized to the
outer surface as shown by proteinase K digestion and immuno-
gold electron microscopy. Plasminogen bound to B. burgdorferi
enolase was converted to active plasmin by the plasminogen acti-
vator uPA (Floden et al., 2011). Noguiera et al. also showed that
BB0337 was associated with the outer membrane and surface
exposed. BB0337 retained its enzymatic activity intrinsic to the
glycolytic pathway, and interacted with plasminogen via lysine
residues. The B. burgdorferi enolase showed variable temporal
and spatial expression in ticks, with expression relatively high in
fed and unfed nymphs. In a mouse model of infection, enolase
demonstrated its highest expression in joints and heart at 28 days
post-infection, while expression in skin disappeared by day 28.
Immunization with BB0337 did not evoke protective immunity
in mice, but did prevent acquisition by ticks (Nogueira et al.,
2012). In contrast, a third group found BB0337 in outer mem-
brane vesicles, but did not detect enolase on the outer surface of
B. burgdorferi by proteinase K digestion or by electronmicroscopy
(Toledo et al., 2012). In addition, Toledo et al. demonstrated
that enolase was recognized by host antibodies from tick-infected
mice, rabbits, and human Lyme disease patients (Toledo et al.,
2012).
OspC
In a recent study, Önder et al. make the case for OspC as the
principal plasminogen-binding protein of B. burgdorferi (Lagal
et al., 2006; Onder et al., 2012). The authors demonstrated
that OspC bound plasminogen in vitro, and also showed co-
localization of plasminogen and OspC on the surface of intact
bacteria. Finally, OspC-deficient bacteria did not appreciably bind
plasminogen, and plasminogen binding was effectively blocked
by anti-OspC antibodies (Onder et al., 2012). The authors note
that these results do not preclude a role for the other identified
plasminogen-binding proteins under different conditions.
CspA (CRASP-1)
CspA binds plasminogen in vitro, and this interaction was inhib-
ited by 6-ACA, a lysine analog. In the presence of uPA, plasmino-
gen bound to CspA was converted to active plasmin (Hallstrom
et al., 2010).
BBA70
Recently, Koenigs et al. described another plasminogen bind-
ing protein of B. burgdorferi, BBA70 (Koenigs et al., 2013). As
with other plasminogen binding proteins, the interaction between
BBA70 and plasminogen was dose-dependent and affected by
ionic strength. This interaction was mediated by lysine residues
in the C-terminus of BBA70. The authors demonstrated that
BBA70 is located on the borrelial outer surface. Plasminogen
bound to BBA70 was converted to active plasmin by urokinase-
type plasminogen activator, and was able to degrade fibrinogen.
Interestingly, BBA70-bound plasmin was able to degrade the
central complement proteins C3b and C5 (Koenigs et al., 2013).
COMPLEMENT REGULATOR ACQUIRING SURFACE PROTEINS
Factor H is a 155 kDa protein present in mammalian serum that
is important for homeostasis of the complement system. Factor
H binds C3b, and accelerates the decay of the alternative path-
way C3 convertase C3bBb, as well as serving as a cofactor for
Factor I-mediated proteolytic inactivation of C3b (Rodriguez de
Cordoba et al., 2004). Factor H consists of 20 short consensus
repeats (SCRs); SCRs 19–20 interact with GAGs, such as heparin,
on the surface of host cells.
There are additional Factor H-like proteins; Factor H-like
protein-1 (FHL-1) is encoded by the same gene, but is a prod-
uct of alternative splicing of the Factor H pre-mRNA. Factor H
related proteins (FHRs) are encoded by separate genes but have
sequence similarities with SCRs 18–20 of Factor H. FHR-1 blocks
the action of the C5 convertase, as well as the membrane attack
complex (MAC) formation, while FHR-5 has cofactor activity for
Factor I-mediated inactivation of C3b (McRae et al., 2005). The
function of FHR2 is unknown.
B. burgdorferi has several proteins which bind Factor
H and its related proteins, initially identified as CRASPs
(Complement Regulator-Acquiring Surface Proteins), includ-
ing CRASP-1 (CspA), CRASP-2 (CspZ), and CRASP-3 (ErpP),
CRASP-4 (ErpC), and CRASP-5 (ErpA) (reviewed in Kraiczy and
Stevenson, 2013). Many of these proteins have multiple designa-
tions in the literature; to avoid confusion, the designations CspA,
CspZ, ErpP, ErpC, and ErpA will be used here.
A number of exciting biochemical and biophysical studies
recently have provided important insights into the interaction
of borrelial Factor H-binding proteins with their ligands. One
study examined the structural basis for complement evasion. The
authors solved the solution structure of ErpP interacting with
Factor H by NMR and X-ray crystallography. Factor H SCR 19–20
interacts with ErpP, reminiscent of how Factor H binds to GAGs
(Bhattacharjee et al., 2013). Another study resolved the atomic
resolution structure of ErpC. This protein consists of 10 antiparal-
lel β strands capped by two α helices. The outer surface is charged,
while the inner surface is hydrophobic. ErpC bound Factor H
through residues within the loops between the β strands (Caesar
et al., 2013a). In contrast, CspA, which forms homodimers, was
shown to consist of 7 α helices joined by short loops. The flexibil-
ity between the subunits may allow for increased access of Factor
H to the binding site. The C terminus of CspA is required for
assembly of a stable dimer (Caesar et al., 2013b). Finally, Meri
et al. showed that ErpA of B. burgdorferi, as well as Factor H
binding proteins from the relapsing fever spirochete B. hermsii
and other pathogens, binds Factor H through a common site in
SCR 20. The authors showed that binding of Factor H by these
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pathogens was inhibited by heparin binding, and that a tripar-
tite complex between the microbial protein, Factor H and C3b is
formed, facilitating complement evasion (Meri et al., 2013).
The contribution of the Factor H-binding proteins to comple-
ment evasion is being heavily investigated not just for B. burgdor-
feri, but also B. afzelii and B. spielmannii. Kenedy and Akins
overexpressed ErpP and ErpA in a cspA-deficient strain. The over-
expression of these proteins enhanced serum resistance and the
amount of Factor H bound to the bacterial surface. Deposition
of complement components C3 and C5b-9 (the MAC complex)
were reduced on the surface when ErpP or ErpA were overex-
pressed (Kenedy and Akins, 2011).
ErpC immobilized on magnetic beads captured Factor H, as
well as FHR-1, -2, and -5 from human serum. However, B. garinii,
which is sensitive to complement killing, expressing ErpC were
still killed by complement (Hammerschmidt et al., 2012), suggest-
ing ErpC alone is insufficient to protect the Lyme bacterium from
complement.
Borrelia spielmanii binds both Factor H and plasminogen, and
is serum resistant. B. spielmanii has a 15 kDa CRASP protein (akin
to the 17–20 kDa ErpA, C, and P proteins of B. burgdorferi) that
was shown to bind Factor H, FHR-1 but not FHL-1. Factor H
bound to BsCRASP maintained its cofactor activity for Factor I-
mediated C3b inactivation. Mutating H79 to alanine abrogated
Factor H binding but not plasminogen binding, demonstrat-
ing independent binding sites on BsCRASP for plasminogen and
Factor H. B. spielmanii also expresses a CspA-like protein (Seling
et al., 2010).
Finally, B. burgdorferi ErpP and ErpA bind FHR-2 and FHR-5.
In contrast, B. garinii CRASPs bind FHR-1, -2, and -5 but not
Factor H. ErpA, ErpC, and ErpP bind Factor H and FHR-1, but
not FHL-1. The binding properties of ErpA, ErpP, and ErpC are
different for the recombinant proteins as compared to the native
proteins. B. burgdorferi lacking CspA and CspZ, which bind both
Factor H and FHL-1, were killed by complement. The balance
of the data suggest that the Lyme Borrelia require acquisition of
Factor H, but not FHRs, to evade complement-mediated killing
(Siegel et al., 2010). A recent review by Kraiczy and Stevenson
neatly summarizes the acquisition of Factor H, FHL-1, and FHRs
by the various B. burgdorferi proteins (Kraiczy and Stevenson,
2013).
CONCLUDING REMARKS
Although much progress has been made in the field, further work
is needed to elucidate the roles of the many identified borrelial
ECM-binding proteins and other adhesins (Table 1). Obstructing
progress are several characteristics inherent to these types of pro-
teins. For instance, redundancy for specific host substrates can
prevent phenotypic characterization of adhesin mutants, as the
lack of one protein may be compensated for by the presence of
several others. Another obstacle for research is the ability of mul-
tiple borrelial proteins to each interact with several substrates.
Defining a role for a given protein during an infection may be
difficult when that protein may fulfill different functions during
the course of an infection. Compounding these issues are the dif-
ferent potential roles for every protein in the infection process
of the bacteria. To be infectious, B. burgdorferi must colonize,
disseminate, and persist in the host, all of which are facilitated
by proteins discussed herein. To this end, these studies high-
light the need to examine adhesins in vitro, in vivo, and with
both loss and gain of function mutants. Determining which stage
or stages of infection each protein participates in will help us
to further understand the biology of the bacteria and poten-
tially allow for novel treatment strategies for Lyme disease. For
example, anti-adhesive therapies that target the initial interac-
tions between bacteria and their host are garnering considerable
interest in this era of antibiotic resistance (Krachler and Orth,
2013). Once the precise roles of these sticky B. burgdorferi pro-
teins are well understood, these adhesins themselves may prove to
be responsive targets for Lyme disease therapies.
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METHODS
This review covers new research published on B. burgdorferi
adhesins from January 2010–October 2013. Search terms on
PubMed: Borrelia + adhesin, Borrelia + fibronectin, Borrelia +
laminin, Borrelia+ decorin, Borrelia+ integrin, Borrelia+ colla-
gen, Borrelia+ proteoglycan, Borrelia + GAG, Borrelia + Factor
H, Borrelia+ plasminogen.
REFERENCES
Alitalo, A., Meri, T., Lankinen, H., Seppala, I., Lahdenne, P., Hefty, P. S., et al.
(2002). Complement inhibitor factor H binding to Lyme disease spirochetes
is mediated by inducible expression of multiple plasmid-encoded outer sur-
face protein E paralogs. J. Immunol. 169, 3847–3853. Available online at:
http://www.jimmunol.org/content/169/7/3847
Antonara, S., Chafel, R. M., LaFrance, M., and Coburn, J. (2007). Borrelia burgdor-
feri adhesins identified using in vivo phage display.Mol. Microbiol. 66, 262–276.
doi: 10.1111/j.1365-2958.2007.05924.x
Antonara, S., Ristow, L., and Coburn, J. (2011). Adhesion mechanisms of
Borrelia burgdorferi. Adv. Exp. Med. Biol. 715, 35–49. doi: 10.1007/978-94-007-
0940-9_3
Antonara, S., Ristow, L., McCarthy, J., and Coburn, J. (2010). Effect of Borrelia
burgdorferi OspC at the site of inoculation in mouse skin. Infect. Immun. 78,
4723–4733. doi: 10.1128/IAI.00464-10
Atzingen, M. V., Barbosa, A. S., De Brito, T., Vasconcellos, S. A., de Morais, Z. M.,
Lima, D. M., et al. (2008). Lsa21, a novel leptospiral protein binding adhesive
matrix molecules and present during human infection. BMC Microbiol. 8:70.
doi: 10.1186/1471-2180-8-70
Bamford, C. V., Francescutti, T., Cameron, C. E., Jenkinson, H. F., and Dymock,
D. (2010). Characterization of a novel family of fibronectin-binding proteins
with M23 peptidase domains from Treponema denticola. Mol. Oral Microbiol.
25, 369–383. doi: 10.1111/j.2041-1014.2010.00584.x
Barthold, S. W., de Souza, M., Fikrig, E., and Persing, D. H. (1992a). “Lyme borre-
liosis in the laboratory mouse,” in Lyme Disease: Molecular and Immunologic
Approaches, ed S. E. Schutzer (Cold Spring Harbor: Cold Spring Harbor
Laboratory Press), 223–242.
Barthold, S. W., de souza, M. S., Janotka, J. L., Smith, A. L., and Persing, D. H.
(1993). Chronic Lyme borreliosis in the laboratory mouse. Am. J. Pathol. 143,
959–972.
Barthold, S. W., Hodzic, E., Tunev, S., and Feng, S. (2006). Antibody-mediated
disease remission in the mouse model of Lyme borreliosis. Infect. Immun. 74,
4817–4825. doi: 10.1128/IAI.00469-06
Frontiers in Cellular and Infection Microbiology www.frontiersin.org April 2014 | Volume 4 | Article 41 | 8
Brissette and Gaultney B. burgdorferi adhesins
Barthold, S.W., Persing, D. H., Armstrong, A. L., and Peeples, R. A. (1991). Kinetics
of Borrelia burgdorferi dissemination and evolution of disease after intradermal
inoculation of mice. Am. J. Pathol. 139, 263–273.
Barthold, S. W., Sidman, C. L., and Smith, A. L. (1992b). Lyme borreliosis in genet-
ically resistant and susceptible mice with severe combined immunodeficiency.
Am. J. Trop. Med. Hyg. 47, 605–613.
Behera, A. K., Durand, E., Cugini, C., Antonara, S., Bourassa, L., Hildebrand,
E., et al. (2008). Borrelia burgdorferi BBB07 interaction with integrin α3β1
stimulates production of pro-inflammatory mediators in primary human
chondrocytes. Cell Microbiol. 10, 320–331. doi: 10.1111/j.1462-5822.2007.
01043.x
Behera, A. K., Hildebrand, E., Uematsu, S., Akira, S., Coburn, J., and Hu, L. T.
(2006). Identification of a TLR-independent pathway for Borrelia burgdorferi-
induced expression of matrix metalloproteinases and inflammatory mediators
through binding to integrin α3β1. J. Immunol. 177, 657–664. Available online at:
http://www.jimmunol.org/content/177/1/657
Benoit, V. M., Fischer, J. R., Lin, Y. P., Parveen, N., and Leong, J. M. (2011). Allelic
variation of the Lyme disease spirochete adhesin DbpA influences spirochetal
binding to decorin, dermatan sulfate, and mammalian cells. Infect. Immun. 79,
3501–3509. doi: 10.1128/IAI.00163-11
Berger, B. W., Johnson, R. C., Kodner, C., and Coleman, L. (1992). Cultivation of
Borrelia burgdorferi from erythemamigrans lesions and perilesional skin. J. Clin.
Microbiol. 30, 359–361.
Bhattacharjee, A., Oeemig, J. S., Kolodziejczyk, R., Meri, T., Kajander, T., Lehtinen,
M. J., et al. (2013). Structural basis for complement evasion by Lyme dis-
ease pathogen Borrelia burgdorferi. J. Biol. Chem. 288, 18685–18695. doi:
10.1074/jbc.M113.459040
Bhattacharya, S., Ploplis, V. A., and Castellino, F. J. (2012). Bacterial plasminogen
receptors utilize host plasminogen system for effective invasion and dissemina-
tion. J. Biomed. Biotechnol. 2012:482096. doi: 10.1155/2012/482096
Blevins, J. S., Hagman, K. E., and Norgard, M. V. (2008). Assessment of decorin-
binding protein A to the infectivity of Borrelia burgdorferi in the murine models
of needle and tick infection. BMCMicrobiol. 8:82. doi: 10.1186/1471-2180-8-82
Brinkman, M. B., McGill, M. A., Pettersson, J., Rogers, A., Matejkova, P., Smajs, D.,
et al. (2008). A novel Treponema pallidum antigen, TP0136, is an outer mem-
brane protein that binds human fibronectin. Infect. Immun. 76, 1848–1857. doi:
10.1128/IAI.01424-07
Brissette, C. A., Bykowski, T., Cooley, A. E., Bowman, A., and Stevenson, B. (2009a).
Borrelia burgdorferi RevA antigen binds host fibronectin. Infect. Immun. 77,
2802–2812. doi: 10.1128/IAI.00227-09
Brissette, C. A., Haupt, K., Barthel, D., Cooley, A. E., Bowman, A., Skerka, C., et al.
(2009b). The Borrelia burgdorferi infection-associated surface proteins ErpP,
ErpA, and ErpC bind human plasminogen. Infect. Immun. 77, 300–306. doi:
10.1128/IAI.01133-08
Brissette, C. A., Rossmann, E., Bowman, A., Cooley, A. E., Riley, S. P., Hunfeld,
K. P., et al. (2010). The borrelial fibronectin-binding protein RevA is an early
antigen of human Lyme disease. Clin. Vaccine Immunol. 17, 274–280. doi:
10.1128/CVI.00437-09
Brissette, C. A., Verma, A., Bowman, A., Cooley, A. E., and Stevenson, B. (2009c).
The Borrelia burgdorferi outer-surface protein ErpX binds mammalian laminin.
Microbiology 155, 863–872. doi: 10.1099/mic.0.024604-0
Brooks, C. S., Vuppala, S. R., Jett, A. M., Alitalo, A., Meri, S., and Akins, D. R.
(2005). Complement regulator-acquiring surface protein 1 imparts resistance
to human serum in Borrelia burgdorferi. J. Immunol. 175, 3299–3308. Available
online at: http://www.jimmunol.org/content/175/5/3299
Brown, E. L., Wooten, R. M., Johnson, B. J., Iozzo, R. V., Smith, A., Dolan, M. C.,
et al. (2001). Resistance to Lyme disease in decorin-deficient mice. J. Clin. Invest.
107, 845–852. doi: 10.1172/JCI11692
Bykowski, T., Woodman, M. E., Cooley, A. E., Brissette, C. A., Brade, V.,
Wallich, R., et al. (2007). Coordinated expression of Borrelia burgdorferi
complement regulator-acquiring surface proteins during the Lyme disease
spirochete’s mammal-tick infection cycle. Infect. Immun. 75, 4227–4236. doi:
10.1128/IAI.00604-07
Cabello, F. C., Godfrey, H. P., and Newman, S. A. (2007). Hidden in plain sight:
Borrelia burgdorferi and the extracellular matrix. Trends Microbiol. 15, 350–354.
doi: 10.1016/j.tim.2007.06.003
Cadavid, D., Bai, Y., Dail, D., Hurd, M., Narayan, K., Hodzic, E., et al.
(2003). Infection and inflammation in skeletal muscle from nonhuman pri-
mates infected with different genospecies of the Lyme disease spirochete
Borrelia burgdorferi. Infect. Immun. 71, 7087–7098. doi: 10.1128/IAI.71.12.7087-
7098.2003
Caesar, J. J., Johnson, S., Kraiczy, P., and Lea, S. M. (2013a). ErpC, a member of
the complement regulator-acquiring family of surface proteins from Borrelia
burgdorferi, possesses an architecture previously unseen in this protein fam-
ily. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 69, 624–628. doi:
10.1107/S1744309113013249
Caesar, J. J., Wallich, R., Kraiczy, P., Zipfel, P. F., and Lea, S. M. (2013b).
Further structural insights into the binding of complement factor H by com-
plement regulator-acquiring surface protein 1 (CspA) of Borrelia burgdor-
feri. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 69, 629–633. doi:
10.1107/S1744309113012748
Cameron, C. E., Brown, E. L., Kuroiwa, J. M., Schnapp, L. M., and Brouwer, N.
L. (2004). Treponema pallidum fibronectin-binding proteins. J. Bacteriol. 186,
7019–7022. doi: 10.1128/JB.186.20.7019-7022.2004
Carroll, J. A., El-Hage, N., Miller, J. C., Babb, K., and Stevenson, B. (2001). Borrelia
burgdorferi RevA antigen is a surface-exposed outer membrane protein whose
expression is regulated in response to environmental temperature and pH.
Infect. Immun. 69, 5286–5293. doi: 10.1128/IAI.69.9.5286-5293.2001
Castellino, F. J., and Ploplis, V. A. (2005). Structure and function of the
plasminogen/plasmin system. Thromb. Haemost. 93, 647–654. doi: 10.1267/
THRO05040647
Chan, K., Awan, M., Barthold, S. W., and Parveen, N. (2012). Comparative
molecular analyses of Borrelia burgdorferi sensu stricto strains B31 and
N40D10/E9 and determination of their pathogenicity. BMC Microbiol. 12:157.
doi: 10.1186/1471-2180-12-157
Choy, H. A., Kelley, M. M., Chen, T. L., Moller, A. K., Matsunaga, J., and Haake, D.
A. (2007). Physiological osmotic induction of Leptospira interrogans adhesion:
LigA and LigB bind extracellular matrix proteins and fibrinogen. Infect. Immun.
75, 2441–2450. doi: 10.1128/IAI.01635-06
Coburn, J., Leong, J., and Chaconas, G. (2013). Illuminating the roles
of the Borrelia burgdorferi adhesins. Trends Microbiol. 21, 372–379. doi:
10.1016/j.tim.2013.06.005
Coburn, J., Leong, J. M., and Erban, J. K. (1993). Integrin aIIbb3 mediates binding
of the Lyme disease agent Borrelia burgdorferi to human platelets. Proc. Natl.
Acad. Sci. U.S.A. 90, 7059–7063. doi: 10.1073/pnas.90.15.7059
Coburn, J., Magoun, L., Bodary, S. C., and Leong, J. M. (1998). Integrins avb3 and
a5b1 mediate attachmant of Lyme disease spirochetes to human cells. Infect.
Immun. 66, 1946–1952.
Coburn, J., Medrano, M., and Cugini, C. (2002). Borrelia burgdorferi and its
tropisms for adhesion molecules in the joint. Curr. Opin. Rheumatol. 14,
394–398. doi: 10.1097/00002281-200207000-00010
Coleman, J. L., Crowley, J. T., Toledo, A. M., and Benach, J. L. (2013). The
HtrA protease of Borrelia burgdorferi degrades outer membrane protein
BmpD and chemotaxis phosphatase CheX. Mol. Microbiol. 88, 619–633. doi:
10.1111/mmi.12213
Coleman, J. L., Gebbia, J. A., Piesman, J., Degen, J. L., Bugge, T. H., and Benach, J.
L. (1997). Plasminogen is required for efficient dissemination of B. burgdorferi
in ticks and for enhancement of spirochetemia in mice. Cell 89, 1111–1119. doi:
10.1016/S0092-8674(00)80298-6
Coleman, J. L., Roemer, E. J., and Benach, J. L. (1999). Plasmin-coated Borrelia
burgdorferi degrades soluble and insoluble components of the mammalian
extracellular matrix. Infect. Immun. 67, 3929–3936.
Coleman, J. L., Sellati, T. J., Testa, J. E., Kew, R. R., Furie, M. B., and Benach,
J. L. (1995). Borrelia burgdorferi binds plasminogen, resulting in enhanced
penetration of endothelial monolayers. Infect. Immun. 63, 2478–2484.
Colognato, H., and Yurchenco, P. D. (2000). Form and function: the laminin fam-
ily of heterotrimers. Dev. Dyn. 218, 213–234. doi: 10.1002/(SICI)1097-0177
(200006)218:2<213::AID-DVDY1>3.0.CO;2-R
Danielson, K. G., Baribault, H., Holmes, D. F., Graham, H., Kadler, K. E., and
Iozzo, R. V. (1997). Targeted disruption of decorin leads to abnormal col-
lagen fibril morphology and skin fragility. J. Cell Biol. 136, 729–743. doi:
10.1083/jcb.136.3.729
Defosse, D. L., Duray, P. H., and Johnson, R. C. (1992). The NIH-3 immunodefi-
cient mouse is a model for Lyme borreliosis myositis and carditis. Am. J. Pathol.
141, 3–10.
De Koning, J., Bosma, R. B., andHoogkamp-Korstanje, J. A. (1987). Demonstration
of spirochaetes in patients with Lyme disease with amodified silver stain. J. Med.
Microbiol. 23, 261–267. doi: 10.1099/00222615-23-3-261
Frontiers in Cellular and Infection Microbiology www.frontiersin.org April 2014 | Volume 4 | Article 41 | 9
Brissette and Gaultney B. burgdorferi adhesins
de Souza, M. S., Smith, A. L., Beck, D. S., Terwilliger, G. A., Fikrig, E., and Barthold,
S. W. (1993). Long-term study of cell-mediated responses to Borrelia burgdorferi
in the laboratory mouse. Infect. Immun. 61, 1814–1822.
Dorward, D. W., Fischer, E. R., and Brooks, D. M. (1997). Invasion and cytopathic
killing of human lymphocytes by spirochetes causing Lyme disease. Clin. Infect.
Dis. 25(Suppl. 1), S2–S8. doi: 10.1086/516169
Dugan, T. A., Yang, V. W., McQuillan, D. J., and Hook, M. (2006). Decorin mod-
ulates fibrin assembly and structure. J. Biol. Chem. 281, 38208–38216. doi:
10.1074/jbc.M607244200
Fischer, J. R., Leblanc, K. T., and Leong, J. M. (2006). Fibronectin binding pro-
tein BBK32 of the Lyme disease spirochete promotes bacterial attachment to
glycosaminoglycans. Infect. Immun. 74, 435–441. doi: 10.1128/IAI.74.1.435-
441.2006
Fischer, J. R., Parveen, N., Magoun, L., and Leong, J. M. (2003). Decorin-binding
proteins A and B confer distinct mammalian cell type-specific attachment by
Borrelia burgdorferi, the Lyme disease spirochete. Proc. Natl. Acad. Sci. U.S.A.
100, 7307–7312. doi: 10.1073/pnas.1231043100
Fitzgerald, T. J., Repesh, L. A., Blanco, D. R., and Miller, J. N. (1984). Attachment
of Treponema pallidum to fibronectin, laminin, collagen IV, and collagen I, and
blockage of attachment by immune rabbit IgG. Br. J. Vener. Dis. 60, 357–363.
doi: 10.1136/sti.60.6.357
Floden, A. M., Gonzalez, T., Gaultney, R. A., and Brissette, C. A. (2013). Evaluation
of RevA, a fibronectin-binding protein of Borrelia burgdorferi, as a potential
vaccine candidate for Lyme disease. Clin. Vaccine Immunol. 20, 892–899. doi:
10.1128/CVI.00758-12
Floden, A. M., Watt, J. A., and Brissette, C. A. (2011). Borrelia burgdorferi eno-
lase is a surface-exposed plasminogen binding protein. PLoS ONE 6:e27502. doi:
10.1371/journal.pone.0027502
Franz, J. K., Fritze, O., Rittig, M., Keysser, G., Priem, S., Zacher, J., et al. (2001).
Insights from a novel three-dimensional in vitro model of Lyme arthritis:
standardized analysis of cellular and molecular interactions between Borrelia
burgdorferi and synovial explants and fibroblasts. Arthritis Rheum. 44, 151–162.
doi: 10.1002/1529-0131(200101)44:1<151::AID-ANR19>3.0.CO;2-E
Fraser, C. M., Casjens, S., Huang, W. M., Sutton, G. G., Clayton, R., Lathigra,
R., et al. (1997). Genomic sequence of a Lyme disease spirochaete, Borrelia
burgdorferi. Nature 390, 580–586. doi: 10.1038/37551
Fuchs, H., Wallich, R., Simon, M. M., and Kramer, M. D. (1994). The outer
surface protein A of the spirochete Borrelia burgdorferi is a plasmin(ogen) recep-
tor. Proc. Natl. Acad. Sci. U.S.A. 91, 12594–12598. doi: 10.1073/pnas.91.26.
12594
Gaultney, R. A., Gonzalez, T., Floden, A. M., and Brissette, C. A. (2013). BB0347,
from the Lyme disease spirochete Borrelia burgdorferi, is surface exposed and
interacts with the CS1 heparin-binding domain of human fibronectin. PLoS
ONE 8:e75643. doi: 10.1371/journal.pone.0075643
Gilmore, R. D. Jr., and Mbow, M. L. (1998). A monoclonal antibody gener-
ated by antigen inoculation via tick bite is reactive to the Borrelia burgdor-
feri Rev protein, a member of the 2.9 gene family locus. Infect. Immun. 66,
980–986.
Grab, D. J., Givens, C., and Kennedy, R. (1998). Fibronectin-binding activity in
Borrelia burgdorferi. Biochim. Biophys. Acta 1407, 135–145. doi: 10.1016/S0925-
4439(98)00038-6
Grimm, D., Tilly, K., Byram, R., Stewart, P. E., Krum, J. G., Bueschel, D. M.,
et al. (2004). Outer-surface protein C of the Lyme disease spirochete: a pro-
tein induced in ticks for infection of mammals. Proc. Nat. Acad. Sci. U.S.A. 101,
3142–3147. doi: 10.1073/pnas.0306845101
Guo, B. P., Brown, E. L., Dorward, D. W., Rosenberg, L. C., and Hook, M.
(1998). Decorin-binding adhesins from Borrelia burgdorferi.Mol. Microbiol. 30,
711–723. doi: 10.1046/j.1365-2958.1998.01103.x
Guo, B. P., Norris, S. J., Rosenberg, L. C., and Höök, M. (1995). Adherence of
Borrelia burgdorferi to the proteoglycan decorin. Infect. Immun. 63, 3467–3472.
Hallstrom, T., Haupt, K., Kraiczy, P., Hortschansky, P., Wallich, R., Skerka, C.,
et al. (2010). Complement regulator-acquiring surface protein 1 of Borrelia
burgdorferi binds to human bone morphogenic protein 2, several extracellu-
lar matrix proteins, and plasminogen. J. Infect. Dis. 202, 490–498. doi: 10.1086/
653825
Hammerschmidt, C., Hallstrom, T., Skerka, C., Wallich, R., Stevenson, B., Zipfel, P.
F., et al. (2012). Contribution of the infection-associated complement regulator-
acquiring surface protein 4 (ErpC) to complement resistance of Borrelia
burgdorferi. Clin. Dev. Immunol. 2012:349657. doi: 10.1155/2012/349657
Hammerschmidt, C., Koenigs, A., Siegel, C., Hallstrom, T., Skerka, C., Wallich,
R., et al. (2014). Versatile roles of CspA orthologs in complement inactivation
of serum-resistant Lyme disease spirochetes. Infect. Immun. 82, 380–392. doi:
10.1128/IAI.01094-13
Hartmann, K., Corvey, C., Skerka, C., Kirschfink, M., Karas, M., Brade, V., et al.
(2006). Functional characterization of BbCRASP-2, a distinct outer membrane
protein of Borrelia burgdorferi that binds host complement regulators factor
H and FHL-1. Mol. Microbiol. 61, 1220–1236. doi: 10.1111/j.1365-2958.2006.
05318.x
Hauk, P., Macedo, F., Romero, E. C., Vasconcellos, S. A., de Morais, Z. M., Barbosa,
A. S., et al. (2008). In LipL32, the major leptospiral lipoprotein, the C terminus
is the primary immunogenic domain and mediates interaction with collagen
IV and plasma fibronectin. Infect. Immun. 76, 2642–2650. doi: 10.1128/IAI.
01639-07
Häupl, T., Hahn, G., Rittig, M., Krause, A., Schoerner, C., Schonherr, U.,
et al. (1993). Persistence of Borrelia burgdorferi in ligamentous tissue from a
patient with chronic Lyme borreliosis. Arthritis Rheum. 36, 1621–1626. doi:
10.1002/art.1780361118
Hellwage, J., Meri, T., Heikkila, T., Alitalo, A., Panelius, J., Lahdenne, P., et al.
(2001). The complement regulator factor H binds to the surface protein OspE
of Borrelia burgdorferi. J. Biol. Chem. 276, 8427–8435. Available online at:
http://www.jbc.org/content/276/11/8427
Henderson, B., Nair, S., Pallas, J., and Williams, M. A. (2011). Fibronectin: a mul-
tidomain host adhesin targeted by bacterial fibronectin-binding proteins. FEMS
Microbiol. Rev. 35, 147–200. doi: 10.1111/j.1574-6976.2010.00243.x
Hu, L. T., Pratt, S. D., Perides, G., Katz, L., Rogers, R. A., and Klempner, M.
S. (1997). Isolation, cloning and expression of a 70-kilodalton plasminogen
binding protein of Borrelia burgdorferi. Infect. Immun. 65, 4989–4995.
Hyde, J. A., Weening, E. H., Chang, M., Trzeciakowski, J. P., Hook, M., Cirillo, J. D.,
et al. (2011). Bioluminescent imaging of Borrelia burgdorferi in vivo demon-
strates that the fibronectin-binding protein BBK32 is required for optimal
infectivity.Mol. Microbiol. 82, 99–113. doi: 10.1111/j.1365-2958.2011.07801.x
Hynes, R. O. (1999). The dynamic dialogue between cells and matrices: implica-
tions of fibronectin’s elasticity. Proc. Natl. Acad. Sci. U.S.A. 96, 2588–2590. doi:
10.1073/pnas.96.6.2588
Imai, D. M., Samuels, D. S., Feng, S., Hodzic, E., Olsen, K., and Barthold, S. W.
(2013). The early dissemination defect attributed to disruption of decorin-
binding proteins is abolished in chronic murine Lyme borreliosis. Infect.
Immun. 81, 1663–1673. doi: 10.1128/IAI.01359-12
Jeffery, C. J. (1999). Moonlighting proteins. Trends Biochem. Sci. 24, 8–11. doi:
10.1016/S0968-0004(98)01335-8
Kariu, T., Yang, X., Marks, C. B., Zhang, X., and Pal, U. (2013). Proteolysis
of BB0323 results in two polypeptides that impact physiologic and infec-
tious phenotypes in Borrelia burgdorferi. Mol. Microbiol. 88, 510–522. doi:
10.1111/mmi.12202
Keene, D. R., San Antonio, J. D., Mayne, R., McQuillan, D. J., Sarris, G., Santoro, S.
A., et al. (2000). Decorin binds near the C terminus of type I collagen. J. Biol.
Chem. 275, 21801–21804. doi: 10.1074/jbc.C000278200
Kenedy, M. R., and Akins, D. R. (2011). The OspE-related proteins inhibit comple-
ment deposition and enhance serum resistance of Borrelia burgdorferi, the Lyme
disease spirochete. Infect. Immun. 79, 1451–1457. doi: 10.1128/IAI.01274-10
Kenedy, M. R., Vuppala, S. R., Siegel, C., Kriaczy, P., and Akins, D. R. (2009). CspA-
mediated binding of human factor H inhibits complement deposition and
confers serum resistance in Borrelia burgdorferi. Infect. Immun. 77, 2773–2782.
doi: 10.1128/IAI.00318-09
Kim, J. H., Singvall, J., Schwarz-Linek, U., Johnson, B. J., Potts, J. R., and
Hook, M. (2004). BBK32, a fibronectin binding MSCRAMM from Borrelia
burgdorferi, contains a disordered region that undergoes a conformational
change on ligand binding. J. Biol. Chem. 279, 41706–41714. doi: 10.1074/jbc.
M401691200
Klempner, M. S., Noring, R., and Rogers, R. A. (1993). Invasion of human skin
fibroblasts by the Lyme disease spirochete, Borrelia burgdorferi. J. Infect. Dis.
167, 1074–1081. doi: 10.1093/infdis/167.5.1074
Koenigs, A., Hammerschmidt, C., Jutras, B. L., Pogoryelov, D., Barthel, D., Skerka,
C., et al. (2013). BBA70 of Borrelia burgdorferi is a novel plasminogen-binding
protein. J. Biol. Chem. 288, 25229–25243. doi: 10.1074/jbc.M112.413872
Kopp, P. A., Schmitt, M., Wellensiek, H. J., and Blobel, H. (1995). Isolation and
characterization of fibronectin-binding sites of Borrelia garinii N34. Infect.
Immun. 63, 3804–3808.
Frontiers in Cellular and Infection Microbiology www.frontiersin.org April 2014 | Volume 4 | Article 41 | 10
Brissette and Gaultney B. burgdorferi adhesins
Kornblatt, A. N., Steere, A. C., and Brownstein, D. G. (1984). Experimental Lyme
disease in rabbits: spirochetes found in erythema migrans and blood. Infect.
Immun. 46, 220–223.
Krachler, A. M., and Orth, K. (2013). Targeting the bacteria-host interface:
strategies in anti-adhesion therapy. Virulence 4, 284–294. doi: 10.4161/viru.
24606
Kraiczy, P., Seling, A., Brissette, C. A., Rossmann, E., Hunfeld, K. P., Bykowski,
T., et al. (2008). Borrelia burgdorferi complement regulator-acquiring surface
protein 2 (CspZ) as a serological marker of human Lyme disease. Clin. Vaccine
Immunol. 15, 484–491. doi: 10.1128/CVI.00415-07
Kraiczy, P., Skerka, C., Kirschfink, M., Brade, V., and Zipfel, P. F. (2001a). Immune
evasion of Borrelia burgdorferi by acquisition of human complement regulators
FHL-1/reconectin and factor H. Eur. J. Immunol. 31, 1674–1684. doi: 10.1002/
1521-4141(200106)31:6<1674::AID-IMMU1674>3.0.CO;2-2
Kraiczy, P., Skerka, C., Kirschfink, M., Zipfel, P. F., and Brade, V. (2001b).
Mechanism of complement resistance of pathogenic Borrelia burgdorferi
isolates. Int. Immunopharmacol. 1, 393–401. doi: 10.1016/S1567-5769(00)
00041-2
Kraiczy, P., and Stevenson, B. (2013). Complement regulator-acquiring surface
proteins of Borrelia burgdorferi: structure, function and regulation of gene
expression. Ticks Tick Borne Dis. 4, 26–34. doi: 10.1016/j.ttbdis.2012.10.039
Kung, F., Anguita, J., and Pal, U. (2013). Borrelia burgdorferi and tick proteins
supporting pathogen persistence in the vector. Future Microbiol. 8, 41–56. doi:
10.2217/fmb.12.121
Labat-Robert, J., Bihari-Varga, M., and Robert, L. (1990). Extracellular matrix.
FEBS Lett. 268, 386–393. doi: 10.1016/0014-5793(90)81291-U
Lafrance, M. E., Pierce, J. V., Antonara, S., and Coburn, J. (2011). The Borrelia
burgdorferi integrin ligand P66 affects gene expression by human cells in culture.
Infect. Immun. 79, 3249–3261. doi: 10.1128/IAI.05122-11
Lagal, V., Portnoi, D., Faure, G., Postic, D., and Baranton, G. (2006). Borrelia
burgdorferi sensu stricto invasiveness is correlated with OspC-plasminogen
affinity.Microbes Infect. 8, 645–652. doi: 10.1016/j.micinf.2005.08.017
Lahteenmaki, K., Kuusela, P., and Korhonen, T. K. (2001). Bacterial plasminogen
activators and receptors. FEMSMicrobiol. Rev. 25, 531–552. doi: 10.1016/S0168-
6445(01)00067-5
Lee, H. R., and Choi, B. K. (2007). Identification of a fibronectin-binding protein of
Treponema lecithinolyticum by two-dimensional gel electrophoresis and ligand
binding assay. Can. J. Microbiol. 53, 1185–1190. doi: 10.1139/W07-086
Leong, J. M., Wang, H., Magoun, L., Field, J. A., Morrissey, P. E., Robbins, D.,
et al. (1998). Different classes of proteoglycans contribute to the attachment
of Borrelia burgdorferi to cultured endothelial and brain cells. Infect. Immun. 66,
994–999.
Li, X., Liu, X., Beck, D. S., Kantor, F. S., and Fikrig, E. (2006). Borrelia burgdorferi
lacking BBK32, a fibronectin-binding protein, retains full pathogenicity. Infect.
Immun. 74, 3305–3313. doi: 10.1128/IAI.02035-05
Lin, T., Gao, L., Zhang, C., Odeh, E., Jacobs, M. B., Coutte, L., et al. (2012).
Analysis of an ordered, comprehensive STM mutant library in infectious
Borrelia burgdorferi: insights into the genes required for mouse infectivity. PLoS
ONE 7:e47532. doi: 10.1371/journal.pone.0047532
Livengood, J. A., and Gilmore, R. D. Jr. (2006). Invasion of human neuronal and
glial cells by an infectious strain of Borrelia burgdorferi. Microbes Infect. 8,
2832–2840. doi: 10.1016/j.micinf.2006.08.014
Liveris, D., Wang, G., Girao, G., Byrne, D. W., Nowakowski, J., McKenna, D.,
et al. (2002). Quantitative detection of Borrelia burgdorferi in 2-millimeter skin
samples of erythemamigrans lesions: correlation of results with clinical and lab-
oratory findings. J. Clin. Microbiol. 40, 1249–1253. doi: 10.1128/JCM.40.4.1249-
1253.2002
Lodish, H. F., and Darnell, J. E. (2000). Integrating Cells into Tissues.New York, NY:
W.H. Freeman.
Ma, Y., Sturrock, A., and Weis, J. J. (1991). Intracellular localization of Borrelia
burgdorferi within human endothelial cells. Infect. Immun. 59, 671–678.
Margos, G., Vollmer, S. A., Ogden, N. H., and Fish, D. (2011). Population genetics,
taxonomy, phylogeny and evolution of Borrelia burgdorferi sensu lato. Infect.
Genet. Evol. 11, 1545–1563. doi: 10.1016/j.meegid.2011.07.022
Mbow, M. L., Gilmore, R. D. Jr., Stevenson, B., Golde, W. T., Piesman, J., and
Johnson, B. J. B. (2002). Borrelia burgdorferi-specific monoclonal antibod-
ies derived from mice primed with Lyme disease spirochete-infected Ixodes
scapularis ticks. Hybrid. Hybridomics 21, 179–182. doi: 10.1089/153685902760
173890
McRae, J. L., Duthy, T. G., Griggs, K. M., Ormsby, R. J., Cowan, P. J., Cromer,
B. A., et al. (2005). Human factor H-related protein 5 has cofactor activity,
inhibits C3 convertase activity, binds heparin and C-reactive protein, and
associates with lipoprotein. J. Immunol. 174, 6250–6256. Available online at:
http://www.jimmunol.org/content/174/10/6250
Melchers, W., Meis, J., Rosa, P., Claas, E., Nohlmans, L., Koopman, R., et al. (1991).
Amplification of Borrelia burgdorferi DNA in skin biopsies from patients with
Lyme disease. J. Clin. Microbiol. 29, 2401–2406.
Meri, T., Amdahl, H., Lehtinen, M. J., Hyvarinen, S., McDowell, J. V., Bhattacharjee,
A., et al. (2013). Microbes bind complement inhibitor factor H via a common
site. PLoS Pathog. 9:e1003308. doi: 10.1371/journal.ppat.1003308
Merien, F., Truccolo, J., Baranton, G., and Perolat, P. (2000). Identification of a 36-
kDa fibronectin-binding protein expressed by a virulent variant of Leptospira
interrogans serovar icterohaemorrhagiae. FEMS Microbiol. Lett. 185, 17–22. doi:
10.1111/j.1574-6968.2000.tb09034.x
Metts, M. S., McDowell, J. V., Theisen, M., Hansen, P. R., andMarconi, R. T. (2003).
Analysis of the OspE determinents involved in binding of Factor H and OspE-
targeting antibodies elicted during Borrelia burgdorferi infection in mice. Infect.
Immun. 71, 3587–3596. doi: 10.1128/IAI.71.6.3587-3596.2003
Midwood, K. S., Mao, Y., Hsia, H. C., Valenick, L. V., and Schwarzbauer, J. E.
(2006). Modulation of cell-fibronectin matrix interactions during tissue repair.
J. Investig. Dermatol. Symp. Proc. 11, 73–78. doi: 10.1038/sj.jidsymp.5650005
Miller, J. C., von Lackum, K., Babb, K., McAlister, J. D., and Stevenson, B. (2003).
Temporal analysis of Borrelia burgdorferi Erp protein expression through-
out the mammal-tick infectious cycle. Infect. Immun. 71, 6943–6952. doi:
10.1128/IAI.71.12.6943-6952.2003
Miller, J. C., von Lackum, K.,Woodman,M. E., and Stevenson, B. (2006). Detection
of Borrelia burgdorferi gene expression during mammalian infection using tran-
scriptional fusions that produce green fluorescent protein. Microb. Pathog. 41,
43–47. doi: 10.1016/j.micpath.2006.04.004
Moody, K. D., Barthold, S. W., Terwilliger, G. A., Beck, D. S., Hansen, G. M., and
Jacoby, R. O. (1990). Experimental chronic Lyme borreliosis in Lewis rats. Am.
J. Trop. Med. Hyg. 42, 165–174.
Morgan, A., and Wang, X. (2013). Novel heparin-binding motif in decorin bind-
ing protein A from strain B31 of Borrelia burgdorferi explains higher binding
affinity. Biochemistry 52, 8237–8245. doi: 10.1021/bi401376u
Moriarty, T. J., Shi, M., Lin, Y. P., Ebady, R., Zhou, H., Odisho, T., et al. (2012).
Vascular binding of a pathogen under shear force through mechanistically dis-
tinct sequential interactions with host macromolecules. Mol. Microbiol. 86,
1116–1131. doi: 10.1111/mmi.12045
Muller,W. A. (2009).Mechanisms of transendothelial migration of leukocytes.Circ.
Res. 105, 223–230. doi: 10.1161/CIRCRESAHA.109.200717
Nogueira, S. V., Smith, A. A., Qin, J. H., and Pal, U. (2012). A surface enolase
participates in Borrelia burgdorferi-plasminogen interaction and contributes
to pathogen survival within feeding ticks. Infect. Immun. 80, 82–90. doi:
10.1128/IAI.05671-11
Norman, M. U., Moriarty, T. J., Dresser, A. R., Millen, B., Kubes, P., and Chaconas,
G. (2008). Molecular mechanisms involved in vascular interactions of the Lyme
disease pathogen in a living host. PLoS Pathog. 4:e1000169. doi: 10.1371/jour-
nal.ppat.1000169
Onder, O., Humphrey, P. T., McOmber, B., Korobova, F., Francella, N., Greenbaum,
D. C., et al. (2012). OspC is potent plasminogen receptor on surface of Borrelia
burgdorferi. J. Biol. Chem. 287, 16860–16868. doi: 10.1074/jbc.M111.290775
Pachner, A. R., Basta, J., Delaney, E., and Hulinska, D. (1995). Localization of
Borrelia burgdorferi in murine Lyme borreliosis by electron microscopy. Am.
J. Trop. Med. Hyg. 52, 128–133.
Pal, U., Wang, P., Yang, X., Samanta, S., Schoen, R., Wormser, G. P., et al. (2008).
Borrelia burgdorferi basic membrane proteins A and B participate in the genesis
of Lyme arthritis. J. Exp. Med. 205, 133–141. doi: 10.1084/jem.20070962
Pancholi, V. (2001). Multifunctional alpha-enolase: its role in diseases. Cell. Mol.
Life Sci. 58, 902–920. doi: 10.1007/PL00000910
Pancholi, V., and Chhatwal, G. S. (2003). Housekeeping enzymes as virulence
factors for pathogens. Int. J. Med. Microbiol. 293, 391–401. doi: 10.1078/1438-
4221-00283
Pancholi, V., and Fischetti, V. A. (1998). alpha-enolase, a novel strong plas-
min(ogen) binding protein on the surface of pathogenic streptococci. J. Biol.
Chem. 273, 14503–14515. doi: 10.1074/jbc.273.23.14503
Pankov, R., and Yamada, K. M. (2002). Fibronectin at a glance. J. Cell Sci. 115,
3861–3863. doi: 10.1242/jcs.00059
Frontiers in Cellular and Infection Microbiology www.frontiersin.org April 2014 | Volume 4 | Article 41 | 11
Brissette and Gaultney B. burgdorferi adhesins
Parveen, N., Cornell, K. A., Bono, J. L., Chamberland, C., Rosa, P., and Leong, J. M.
(2006). Bgp, a secreted glycosaminoglycan-binding protein of Borrelia burgdor-
feri strain N40, displays nucleosidase activity and is not essential for infection
of immunodeficient mice. Infect. Immun. 74, 3016–3020. doi: 10.1128/IAI.74.5.
3016-3020.2006
Parveen, N., and Leong, J. M. (2000). Identification of a candidate
glycosaminoglycan-binding adhesin of the Lyme disease spirochete Borrelia
burgdorferi. Mol. Microbiol. 35, 1220–1234. doi: 10.1046/j.1365-2958.2000.
01792.x
Parveen, N., Robbins, D., and Leong, J. M. (1999). Strain variation in glycosamino-
glycan recognition influences cell-type-specific binding by Lyme disease spiro-
chetes. Infect. Immun. 67, 1743–1749.
Probert, W. S., and Johnson, B. J. B. (1998). Identification of a 47 kDA fibronectin-
binding protein expressed by Borrelia burgdorferi isolate B31.Mol. Microbiol. 30,
1003–1015. doi: 10.1046/j.1365-2958.1998.01127.x
Probert, W. S., Kim, J. H., Hook, M., and Johnson, B. J. (2001). Mapping the ligand-
binding region of Borrelia burgdorferi fibronectin-binding protein BBK32.
Infect. Immun. 69, 4129–4133. doi: 10.1128/IAI.69.6.4129-4133.2001
Raibaud, S., Schwarz-Linek, U., Kim, J. H., Jenkins, H. T., Baines, E. R.,
Gurusiddappa, S., et al. (2005). Borrelia burgdorferi binds fibronectin through a
tandem beta-zipper, a common mechanism of fibronectin binding in staphy-
lococci, streptococci, and spirochetes. J. Biol. Chem. 280, 18803–18809. doi:
10.1074/jbc.M501731200
Ranka, R., Petrovskis, I., Sominskaya, I., Bogans, J., Bruvere, R., Akopjana, I., et al.
(2013). Fibronectin-binding nanoparticles for intracellular targeting addressed
by protein fragments. Nanomedicine 9, 65–73. doi: 10.1016/j.nano.2012.
05.003
Ristow, L. C., Miller, H. E., Padmore, L. J., Chettri, R., Salzman, N., Caimano,
M. J., et al. (2012). The beta(3)-integrin ligand of Borrelia burgdorferi is crit-
ical for infection of mice but not ticks. Mol. Microbiol. 85, 1105–1118. doi:
10.1111/j.1365-2958.2012.08160.x
Rodriguez de Cordoba, S., Esparza-Gordillo, J., Goicoechea de Jorge, E., Lopez-
Trascasa, M., and Sanchez-Corral, P. (2004). The human complement factor H:
functional roles, genetic variations and disease associations. Mol. Immunol. 41,
355–367. doi: 10.1016/j.molimm.2004.02.005
Rogers, E. A., Abdunnur, S. V., McDowel, J. V., and Marconi, R. T. (2009).
Comparative analysis of the properties and ligand binding characteristics
of CspZ, a factor H binding protein, derived from Borrelia burgdorferi
isolates of human origin. Infect. Immun. 77, 4396–4405. doi: 10.1128/IAI.
00393-09
Rogers, E. A., and Marconi, R. T. (2007). Delineation of species-specific binding
properties of the CspZ (BBH06) of Lyme disease spirochetes: evidence for new
contributions to the pathogenesis of Borrelia spp. Infect. Immun. 75, 5272–5281.
doi: 10.1128/IAI.00850-07
Romberger, D. J. (1997). Fibronectin. Int. J. Biochem. Cell Biol. 29, 939–943. doi:
10.1016/S1357-2725(96)00172-0
Russell, T. M., Delorey, M. J., and Johnson, B. J. (2013). Borrelia burgdorferi BbHtrA
degrades host ECM proteins and stimulates release of inflammatory cytokines
in vitro.Mol. Microbiol. 90, 241–251. doi: 10.1111/mmi.12377
Russell, T. M., and Johnson, B. J. (2013). Lyme disease spirochaetes possess
an aggrecan-binding protease with aggrecanase activity. Mol. Microbiol. 90,
228–240. doi: 10.1111/mmi.12276
Salo, J., Loimaranta, V., Lahdenne, P., Viljanen, M. K., and Hytonen, J. (2011).
Decorin binding by DbpA and B of Borrelia garinii, Borrelia afzelii, and
Borrelia burgdorferi sensu stricto. J. Infect. Dis. 204, 65–73. doi: 10.1093/infdis/
jir207
Sanderson-Smith, M. L., De Oliveira, D. M., Ranson, M., and McArthur, J. D.
(2012). Bacterial plasminogen receptors: mediators of a multifaceted relation-
ship. J. Biomed. Biotechnol. 2012:272148. doi: 10.1155/2012/272148
Schmit, V. L., Patton, T. G., and Gilmore, R. D. Jr. (2011). Analysis of Borrelia
burgdorferi surface proteins as determinants in establishing host cell interac-
tions. Front. Microb. 2:141. doi: 10.3389/fmicb.2011.00141
Schneppenheim, R., and Budde, U. (2011). von Willebrand factor: the complex
molecular genetics of a multidomain and multifunctional protein. J. Thromb.
Haemost. 9(Suppl. 1), 209–215. doi: 10.1111/j.1538-7836.2011.04324.x
Schwan, T. G., Burgdorfer, W., Schrumpf, M. E., and Karstens, R. H. (1988).
The urinary bladder, a consistent source of Borrelia burgdorferi in experimen-
tally infected white-footed mice (Peromyscus leucopus). J. Clin. Microbiol. 26,
893–895.
Schwartz, I., Wormser, G. P., Schwartz, J. J., Cooper, D., Weissensee, P., Gazumyan,
A., et al. (1992). Diagnosis of early Lyme disease by polymerase chain reaction
amplification and culture of skin biopsies from erythema migrans lesions.
J. Clin. Microbiol. 30, 3082–3088.
Schwarz-Linek, U., Hook, M., and Potts, J. R. (2004). The molecular basis of
fibronectin-mediated bacterial adherence to host cells. Mol. Microbiol. 52,
631–641. doi: 10.1111/j.1365-2958.2004.04027.x
Schwarz-Linek, U., Hook, M., and Potts, J. R. (2006). Fibronectin-binding proteins
of gram-positive cocci. Microbes Infect. 8, 2291–2298. doi: 10.1016/j.micinf.
2006.03.011
Seidler, D. G. (2012). The galactosaminoglycan-containing decorin and its impact
on diseases. Curr. Opin. Struct. Biol. 22, 578–582. doi: 10.1016/j.sbi.2012.07.012
Seling, A., Siegel, C., Fingerle, V., Jutras, B. L., Brissette, C. A., Skerka, C., et al.
(2010). Functional characterization of Borrelia spielmanii outer surface pro-
teins that interact with distinct members of the human factor H protein
family and with plasminogen. Infect. Immun. 78, 39–48. doi: 10.1128/IAI.
00691-09
Seshu, J., Esteve-Gassent, M. D., Labandeira-Rey, M., Kim, J. H., Trzeciakowski, J.
P., Hook, M., et al. (2006). Inactivation of the fibronectin-binding adhesin gene
bbk32 significantly attenuates the infectivity potential of Borrelia burgdorferi.
Mol. Microbiol. 59, 1591–1601. doi: 10.1111/j.1365-2958.2005.05042.x
Shi, Y., Xu, Q., McShan, K., and Liang, F. T. (2008a). Both decorin-binding pro-
teins A and B are critical for the overall virulence of Borrelia burgdorferi. Infect.
Immun. 76, 1239–1246. doi: 10.1128/IAI.00897-07
Shi, Y., Xu, Q., Seemanapalli, S. V., McShan, K., and Liang, F. T. (2006). The dbpBA
locus of Borrelia burgdorferi is not essential for infection of mice. Infect. Immun.
74, 6509–6512. doi: 10.1128/IAI.00740-06
Shi, Y., Xu, Q., Seemanaplli, S. V., McShan, K., and Liang, F. T. (2008b). Common
and unique contributions of decorin-binding proteins A and B to the over-
all virulence of Borrelia burgdorferi. PLoS ONE 3:e3340. doi: 10.1371/jour-
nal.pone.0003340
Shih, C.-M., Pollack, R. J., Telford, S. R., and Spielman, A. (1992). Delayed dissem-
ination of Lyme disease spirochetes from the site of deposition in the skin of
mice. J. Infect. Dis. 166, 827–831. doi: 10.1093/infdis/166.4.827
Siegel, C., Hallstrom, T., Skerka, C., Eberhardt, H., Uzonyi, B., Beckhaus, T.,
et al. (2010). Complement factor H-related proteins CFHR2 and CFHR5 rep-
resent novel ligands for the infection-associated CRASP proteins of Borrelia
burgdorferi. PLoS ONE 5:e13519. doi: 10.1371/journal.pone.0013519
Sinsky, R. J., and Piesman, J. (1989). Ear punch biopsy method for detection and
isolation of Borrelia burgdorferi from rodents. J. Clin. Microbiol. 27, 1723–1727.
Stanek, G., and Reiter, M. (2011). The expanding Lyme Borrelia complex–clinical
significance of genomic species? Clin. Microbiol. Infect. 17, 487–493. doi:
10.1111/j.1469-0691.2011.03492.x
Stanek, G., Wormser, G. P., Gray, J., and Strle, F. (2012). Lyme borreliosis. Lancet
379, 461–473. doi: 10.1016/S0140-6736(11)60103-7
Steere, A. C. (2001). Lyme disease. N. Engl. J. Med. 345, 115–125. doi:
10.1056/NEJM200107123450207
Stevenson, B., Choy, H. A., Pinne, M., Rotondi, M. L., Miller, M. C., Demoll,
E., et al. (2007). Leptospira interrogans endostatin-like outer membrane pro-
teins bind host fibronectin, laminin and regulators of complement. PLoS ONE
2:e1188. doi: 10.1371/journal.pone.0001188
Szczepanski, A., Furie, M. B., Benach, J. L., Lane, B. P., and Fleit, H. B. (1990).
Interaction between Borrelia burgdorferi and endothelium in vitro. J. Clin. Invest.
85, 1637–1647. doi: 10.1172/JCI114615
Takada, Y., Ye, X., and Simon, S. (2007). The integrins. Genome Biol. 8:215. doi:
10.1186/gb-2007-8-5-215
Tilly, K., Bestor, A., Jewett, M. W., and Rosa, P. (2007). Rapid clearance of Lyme
disease spirochetes lacking OspC from skin. Infect. Immun. 75, 1517–1519. doi:
10.1128/IAI.01725-06
Tilly, K., Krum, J. G., Bestor, A., Jewett, M. W., Grimm, D., Bueschel, D., et al.
(2006). Borrelia burgdorferi OspC protein required exclusively in a crucial early
stage of mammalian infection. Infect. Immun. 74, 3554–3564. doi: 10.1128/IAI.
01950-05
Toledo, A., Coleman, J. L., Kuhlow, C. J., Crowley, J. T., and Benach, J. L. (2012).
The enolase of Borrelia burgdorferi is a plasminogen receptor released in outer
membrane vesicles. Infect. Immun. 80, 359–368. doi: 10.1128/IAI.05836-11
Umemoto, T., Nakatani, Y., Nakamura, Y., and Namikawa, I. (1993). Fibronectin-
binding proteins of a human oral spirochete Treponema denticola. Microbiol.
Immunol. 37, 75–78. doi: 10.1111/j.1348-0421.1993.tb03182.x
Frontiers in Cellular and Infection Microbiology www.frontiersin.org April 2014 | Volume 4 | Article 41 | 12
Brissette and Gaultney B. burgdorferi adhesins
Varki, A. (2009). Essentials of Glycobiology. Cold Spring Harbor, N.Y: Cold Spring
Harbor Laboratory Press.
Verma, A., Brissette, C. A., Bowman, A., and Stevenson, B. (2009). Borrelia burgdor-
feri BmpA is a laminin-binding protein. Infect. Immun. 77, 4940–4946. doi:
10.1128/IAI.01420-08
Wang, X. (2012). Solution structure of decorin-binding protein A from Borrelia
burgdorferi. Biochemistry 51, 8353–8362. doi: 10.1021/bi3007093
Watanabe, H., Yamada, Y., and Kimata, K. (1998). Roles of aggrecan, a large chon-
droitin sulfate proteoglycan, in cartilage structure and function. J. Biochem. 124,
687–693. doi: 10.1093/oxfordjournals.jbchem.a022166
Weening, E. H., Parveen, N., Trzeciakowski, J. P., Leong, J. M., Hook, M., and
Skare, J. T. (2008). Borrelia burgdorferi lacking DbpBA exhibit an early sur-
vival defect during experimental infection. Infect. Immun. 76, 5694–5705. doi:
10.1128/IAI.00690-08
Wood, E., Tamborero, S., Mingarro, I., and Esteve-Gassent, M. D. (2013). BB0172,
a Borrelia burgdorferi outer membrane protein that binds integrin alpha3beta1.
J. Bacteriol. 195, 3320–3330. doi: 10.1128/JB.00187-13
Wu, J., Weening, E. H., Faske, J. B., Hook, M., and Skare, J. T. (2011). Invasion of
eukaryotic cells by Borrelia burgdorferi requires beta(1) integrins and Src kinase
activity. Infect. Immun. 79, 1338–1348. doi: 10.1128/IAI.01188-10
Wynne, S. A., Crowther, R. A., and Leslie, A. G. (1999). The crystal structure of
the human hepatitis B virus capsid. Mol. Cell 3, 771–780. doi: 10.1016/S1097-
2765(01)80009-5
Xu, Q., McShan, K., and Liang, F. T. (2008). Essential protective role attributed
to the surface lipoproteins of Borrelia burgdorferi against innate defences. Mol.
Microbiol. 69, 15–29. doi: 10.1111/j.1365-2958.2008.06264.x
Yang, X., Izadi, H., Coleman, A. S., Wang, P., Ma, Y., Fikrig, W., et al. (2008).
Borrelia burgdorferi lipoprotein BmpA activates pro-inflammatory responses in
human synovial cells through a protein moiety. Microbes Infect. 10, 1300–1308.
doi: 10.1016/j.micinf.2008.07.029
Zambrano, M. C., Beklemisheva, A. A., Bryksin, A. V., Newman, S. A., and Cabello,
F. C. (2004). Borrelia burgdorferi binds to, invades, and colonizes native type
I collagen lattices. Infect. Immun. 72, 3138–3146. doi: 10.1128/IAI.72.6.3138-
3146.2004
Zhang, G., Ezura, Y., Chervoneva, I., Robinson, P. S., Beason, D. P., Carine, E.
T., et al. (2006). Decorin regulates assembly of collagen fibrils and acquisition
of biomechanical properties during tendon development. J. Cell. Biochem. 98,
1436–1449. doi: 10.1002/jcb.20776
Conflict of Interest Statement: The authors declare that the research was con-
ducted in the absence of any commercial or financial relationships that could be
construed as a potential conflict of interest.
Received: 20 December 2013; accepted: 18 March 2014; published online: 03 April
2014.
Citation: Brissette CA and Gaultney RA (2014) That’s my story, and I’m sticking to
it—an update on B. burgdorferi adhesins. Front. Cell. Infect. Microbiol. 4:41. doi:
10.3389/fcimb.2014.00041
This article was submitted to the journal Frontiers in Cellular and Infection
Microbiology.
Copyright © 2014 Brissette and Gaultney. This is an open-access article distributed
under the terms of the Creative Commons Attribution License (CC BY). The use, dis-
tribution or reproduction in other forums is permitted, provided the original author(s)
or licensor are credited and that the original publication in this journal is cited, in
accordance with accepted academic practice. No use, distribution or reproduction is
permitted which does not comply with these terms.
Frontiers in Cellular and Infection Microbiology www.frontiersin.org April 2014 | Volume 4 | Article 41 | 13
